Myrislignan-13C,d2
Myrislignan-13C,d2 is the 13C, d2 deuterated-labeled Myrislignan (HY-N0608). Myrislignan is a PI3K/AKT/NF-κB inhibitor that can cross the blood-brain barrier. Myrislignan exerts anticancer activity by inducing apoptosis and ferroptosis. Myrislignan inhibits the replication and invasion of Toxoplasma gondii; it induces reactive oxygen species (ROS) imbalance, autophagy, and the death of Toxoplasma gondii tachyzoites. Myrislignan inhibits mitochondrial function and ERK1/2 phosphorylation to improve ovariectomy-induced osteoporosis. Myrislignan can be used in studies related to gastric cancer, glioblastoma, osteoporosis, and toxoplasmosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C2013CH24D2O6
- Peso molecular:377.43
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Aplicación
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
Unlabeled CAS 171485-39-5
-
Peso molecular 377.43
-
Fòrmula C2013CH24D2O6
-
SMILES
C[C@@H]([C@@H](C1=CC(OC)=C(O)C=C1)O)OC(C(OC)=CC(C/C=[13C]([2H])/[2H])=C2)=C2OC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Myrislignan-13C,d2
- Isotope-Labeled Compounds
- NF-κB
- PI3K
- Akt
- Apoptosis
- Ferroptosis
- Reactive Oxygen Species (ROS)
- Autophagy
- ERK
- Nuclear factor-κB
- Nuclear factor-kappaB
- Phosphoinositide 3-kinase
- PKB
- Protein kinase B
- Extracellular signal regulated kinases
- gastric cancer
- U87 cells
- glioblastoma
- osteoporosis
- apoptosis
- SGC-7901 cells
- AKT
- ferroptosis
- Toxoplasma gondii
- Inhibitor
- inhibitor
- inhibit